Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Osipenko MA et al. | 2008 | intact cell/cell culture, fibroblasts (from mouse embryos), animal, mouse embryos | geomagnetic field, shielding/field deprivation | 200 nT |
Mo WC et al. | 2016 | - | geomagnetic field, shielding/field deprivation | - |
Vale P | 2018 | dinoflagellate <i>Gymnodinium catenatum</i> | geomagnetic field, static magnetic field, co-exposure, also other exposures without EMF | - |
Mattsson MO et al. | 2001 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) from three different sources | magnetic field, 50/60 Hz, static magnetic field, shielding/field deprivation | 150 µT |
Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Novikov VV et al. | 2009 | animal, mouse/BALB/c, whole body | magnetic field, static magnetic field | 100 nT–42 µT |
Manjua AC et al. | 2021 | intact cell/cell culture, human bone marrow-derived stromal cells (BMSCs) | magnetic field, static magnetic field | - |
Funnell JL et al. | 2021 | intact cell/cell culture, dorsal root ganglion (rat) | magnetic field, static magnetic field, also other exposures without EMF, co-exposure | - |
Pate K et al. | 2003 | intact cell/cell culture, MRC-5 (human diploid fibroblasts) | magnetic field, static magnetic field, low frequency | - |
Ledda M et al. | 2013 | intact cell/cell culture, NT2 (human pluripotent embryonal carcinoma cells) | magnetic field, static magnetic field, low frequency | 2.5–10 µT |
De Carlo F et al. | 2012 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | magnetic field, static magnetic field, low frequency, co-exposure, therapeutic/medical device | 18 µT |
Anton-Leberre V et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, static magnetic field, signals/pulses, DC | 14–55 T |
Sutter BC et al. | 1987 | animal, rat/Wistar, whole body | static magnetic field | 400–800 mT |
Chionna A et al. | 2005 | intact cell/cell culture, Hep G2 cells (hepatic transformed cell line) | static magnetic field | 6 mT |
Triampo W et al. | 2004 | bacterium, <i>Leptospira interrogans</i> serovar <i>canicola</i> | static magnetic field | 140 mT |
Teodori L et al. | 2006 | intact cell/cell culture, human glioblastoma cells | static magnetic field | 8–300 mT |
Huang HM et al. | 2006 | intact cell/cell culture, MG63 (osteoblast-like cells) | static magnetic field | 0.4 T |
Tenuzzo B et al. | 2006 | intact cell/cell culture, human lymphocytes, mouse thymocytes, FRTL-5 cells (Fischer rat thyroid cells), Hep G2 cells (hepatic transformed cell line), HeLa cell line (human adenocarcinoma cell line), U937 (human leukemic monocyte cell line) and 3 DO cells (T cell hybridoma cell li | static magnetic field | 6 mT |
Chionna A et al. | 2003 | intact cell/cell culture, U937 (human leukemic monocyte cell line) and human lymphocytes | static magnetic field | 6 mT |
Pagliara P et al. | 2005 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | static magnetic field | 6 mT |
Peric-Mataruga V et al. | 2006 | invertebrate, mealworm beetle pupae (<i>Tenebrio molitor</i>) | static magnetic field | 320 mT |
Gorczynska E | 1987 | animal, guinea pig, whole body | static magnetic field | 5–300 mT |
Chiu KH et al. | 2007 | intact cell/cell culture, MG63 (osteoblast-like cells) | static magnetic field | 0.1–0.4 T |
Coletti D et al. | 2007 | intact cell/cell culture, L6 cells (rat myogenic cells) | static magnetic field | 80 mT |
Xu C et al. | 2008 | intact cell/cell culture, human periodontal ligament cells | static magnetic field | 10–120 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.